Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C
| Issuer: Xtrackers |
| Asset Class: Equity |
| TER: 35bps |
| Trading Currency: USD |
| Pays Income: False |
| Listing Date: 13 Feb 2023 |
| Ticker: XDG3 |
| ISIN: IE00036F4K40 |
This investment product offers targeted exposure to global companies that are aligned with the United Nations Sustainable Development Goal 3 (SDG 3): "Good Health and Well-being." It invests in a diversified portfolio of publicly listed firms from both developed and emerging markets whose products or services contribute to promoting health and wellness. The strategy focuses on identifying companies that are not only financially sound but also demonstrate a positive impact on global health outcomes. This includes businesses in pharmaceuticals, biotechnology, healthcare equipment and services, as well as companies involved in promoting healthy lifestyles and well-being.
Investing in this product allows individuals to align their capital with a critical global objective, tapping into the long-term growth potential of the healthcare sector. The demand for innovative health solutions is structurally increasing due to factors such as aging populations, rising middle classes in emerging economies, and ongoing advancements in medical technology. By concentrating on companies that are actively contributing to SDG 3, the portfolio gains exposure to leaders in healthcare innovation and resilient business models. This approach offers a way to potentially generate competitive financial returns while supporting companies that are making a tangible difference in people's lives worldwide, from developing life-saving drugs to making healthcare more accessible.
This thematic strategy is suitable for investors seeking to combine financial goals with a positive social impact. It is designed for those with a long-term investment horizon who believe in the enduring growth of the global healthcare industry and wish to contribute to a more sustainable and healthier future. It can serve as a core thematic holding within a diversified portfolio, providing specific exposure to companies at the forefront of tackling global health challenges. The focus on SDG alignment adds a layer of non-financial screening, which may appeal to investors who prioritize environmental, social, and governance (ESG) criteria in their investment decisions.
